XPO1 and non-Hodgkin lymphoma: STAT3 has been identified as XPO1 cargo in breast cancer [23], and although it has not yet been validated in lymphoma, its importance in immune cell maturation and activation and presence of a bona fide XPO1 binding NES suggests that it is most likely an XPO1 cargo molecule in NHL.